Align (ALGN) Stock Forecast, Price Target & Predictions
ALGN Stock Forecast
Align stock forecast is as follows: an average price target of $554.38 (represents a 127.46% upside from ALGN’s last price of $243.73) and a rating consensus of 'Buy', based on 14 wall street analysts offering a 1-year stock forecast.
ALGN Price Target
The average price target for Align (ALGN) is $554.38 based on 1-year price targets from 14 Wall Street analysts in the past 3 months, with a price target range of $790.00 to $315.00. This represents a potential 127.46% upside from ALGN's last price of $243.73.
ALGN Analyst Ratings
According to 14 Wall Street analysts, Align's rating consensus is 'Buy'. The analyst rating breakdown for ALGN stock is 0 'Strong Buy' (0.00%), 9 'Buy' (64.29%), 5 'Hold' (35.71%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Align Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | Jason Bednar | Piper Sandler | $315.00 | $226.05 | 39.35% | 29.24% |
| Jul 22, 2024 | Jeff Johnson | Robert W. Baird | $325.00 | $251.60 | 29.17% | 33.34% |
| Jun 21, 2024 | Jason Bednar | Piper Sandler | $330.00 | $242.61 | 36.02% | 35.40% |
| Apr 25, 2024 | Jason Bednar | Piper Sandler | $375.00 | $305.00 | 22.95% | 53.86% |
| Apr 25, 2024 | Jeff Johnson | Robert W. Baird | $370.00 | $313.78 | 17.92% | 51.81% |
| Apr 18, 2024 | Jonathan Block | Stifel Nicolaus | $400.00 | $300.14 | 33.27% | 64.12% |
| Mar 15, 2024 | Jonathan Block | Stifel Nicolaus | $350.00 | $314.35 | 11.34% | 43.60% |
| Mar 13, 2024 | Jason Bednar | Piper Sandler | $355.00 | $320.69 | 10.70% | 45.65% |
| Sep 09, 2022 | Jason Bednar | Piper Sandler | $340.00 | $257.30 | 32.14% | 39.50% |
| Jul 26, 2022 | Jonathan Block | Stifel Nicolaus | $375.00 | $252.07 | 48.77% | 53.86% |
The latest Align stock forecast, released on Jul 25, 2024 by Jason Bednar from Piper Sandler, set a price target of $315.00, which represents a 39.35% increase from the stock price at the time of the forecast ($226.05), and a 29.24% increase from ALGN last price ($243.73).
Align Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 3 | 8 |
| Avg Price Target | - | $323.33 | $352.50 |
| Last Closing Price | $243.73 | $243.73 | $243.73 |
| Upside/Downside | -100.00% | 32.66% | 44.63% |
In the current month, the average price target of Align stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Align's last price of $243.73. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 13, 2024 | Sandler O'Neill | Buy | Buy | Hold |
| Sep 13, 2024 | Sandler O'Neil | Underperform | Underperform | Hold |
| Sep 13, 2024 | Piper Sandler | Overweight | Overweight | Hold |
| Aug 15, 2024 | Piper Sandler | Overweight | Overweight | Hold |
| Jul 25, 2024 | Piper Sandler | Overweight | Overweight | Hold |
| Jul 22, 2024 | Sandler O'Neill | Outperform | Outperform | Hold |
| Jul 22, 2024 | Sandler O'Neil | Underperform | Underperform | Hold |
| Jun 21, 2024 | Piper Sandler | Overweight | Overweight | Hold |
| Jun 04, 2024 | OTR Global | Positive | Mixed | Downgrade |
| May 16, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Align's last stock rating was published by Sandler O'Neill on Sep 13, 2024. The company gave ALGN a "Buy" rating, the same as its previous rate.
Align Financial Forecast
Align Revenue Forecast
| Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $956.73M | $960.21M | $1.00B | $943.15M | $901.51M | $890.35M | $969.55M | $973.22M | $1.03B | $1.02B | $1.01B | $894.77M | $834.52M | $734.14M | $352.31M |
| Avg Forecast | $1.63B | $1.57B | $1.52B | $1.23B | $1.19B | $1.21B | $1.16B | $1.12B | $1.09B | $1.11B | $1.05B | $1.02B | $989.86M | $1.04B | $974.53M | $933.67M | $994.48M | $991.34M | $903.21M | $891.81M | $963.76M | $984.66M | $1.00B | $1.02B | $977.81M | $947.35M | $818.18M | $791.05M | $529.26M | $325.21M |
| High Forecast | $1.64B | $1.58B | $1.52B | $1.23B | $1.19B | $1.22B | $1.16B | $1.13B | $1.09B | $1.12B | $1.06B | $1.03B | $991.62M | $1.04B | $980.26M | $940.24M | $1.01B | $997.17M | $908.51M | $897.05M | $969.42M | $988.62M | $1.01B | $1.03B | $981.75M | $951.16M | $821.47M | $794.23M | $531.39M | $326.52M |
| Low Forecast | $1.58B | $1.53B | $1.47B | $1.19B | $1.16B | $1.18B | $1.12B | $1.09B | $1.06B | $1.08B | $1.03B | $993.83M | $987.62M | $1.01B | $948.17M | $930.08M | $978.38M | $964.52M | $878.77M | $867.68M | $937.68M | $970.44M | $987.50M | $1.01B | $963.69M | $933.67M | $806.36M | $779.62M | $521.62M | $320.51M |
| # Analysts | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 4 | 5 | 9 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 | 4 | 4 | 4 | 9 | 9 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 0.97% | 1.01% | 1.04% | 1.01% | 0.92% | 0.98% | 0.97% | 1.01% | 1.04% | 1.07% | 1.09% | 1.05% | 1.39% | 1.08% |
Align's average Quarter revenue forecast for Mar 24 based on 4 analysts is $974.53M, with a low forecast of $948.17M, and a high forecast of $980.26M. ALGN's average Quarter revenue forecast represents a 1.86% increase compared to the company's last Quarter revenue of $956.73M (Dec 23).
Align EBITDA Forecast
| Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 4 | 5 | 9 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 | 4 | 4 | 4 | 9 | 9 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $171.54M | $166.35M | $171.93M | $133.52M | $135.57M | $143.66M | $188.20M | $198.08M | $220.89M | $289.60M | $294.69M | $287.26M | $239.31M | $209.03M | $-49.95M |
| Avg Forecast | $323.28M | $312.09M | $301.29M | $243.62M | $236.20M | $241.17M | $229.70M | $223.08M | $215.79M | $220.78M | $209.53M | $203.13M | $196.85M | $206.36M | $249.40M | $185.67M | $197.76M | $197.14M | $226.72M | $177.35M | $285.48M | $195.81M | $206.11M | $203.50M | $194.45M | $188.39M | $220.42M | $157.31M | $105.25M | $64.67M |
| High Forecast | $325.18M | $313.93M | $303.06M | $245.06M | $237.59M | $242.59M | $231.05M | $224.39M | $217.06M | $222.07M | $210.76M | $204.32M | $197.20M | $207.58M | $299.28M | $186.98M | $200.16M | $198.30M | $272.07M | $178.39M | $342.58M | $196.60M | $247.33M | $204.32M | $195.23M | $189.15M | $264.50M | $157.94M | $105.67M | $64.93M |
| Low Forecast | $314.53M | $303.65M | $293.14M | $237.03M | $229.81M | $234.65M | $223.48M | $217.04M | $209.95M | $214.80M | $203.86M | $197.64M | $196.40M | $200.78M | $199.52M | $184.96M | $194.56M | $191.81M | $181.38M | $172.55M | $228.38M | $192.98M | $164.89M | $200.56M | $191.64M | $185.67M | $176.34M | $155.04M | $103.73M | $63.74M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.92% | 0.84% | 0.87% | 0.59% | 0.76% | 0.50% | 0.96% | 0.96% | 1.09% | 1.49% | 1.56% | 1.30% | 1.52% | 1.99% | -0.77% |
4 analysts predict ALGN's average Quarter EBITDA for Mar 24 to be $249.40M, with a high of $299.28M and a low of $199.52M. This is 45.38% upper than Align's previous annual EBITDA (Dec 23) of $171.54M.
Align Net Income Forecast
| Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 4 | 5 | 9 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 | 4 | 4 | 4 | 9 | 9 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $124.01M | $121.43M | $111.81M | $87.80M | $41.77M | $72.70M | $112.80M | $134.30M | $190.96M | $180.97M | $199.71M | $200.38M | $158.99M | $139.37M | $-40.60M |
| Avg Forecast | $194.00M | $191.73M | $171.02M | $250.61M | $227.13M | $225.52M | $206.45M | $218.52M | $198.21M | $200.82M | $175.80M | $193.26M | $173.78M | $175.74M | $169.09M | $163.68M | $170.19M | $153.07M | $153.72M | $115.46M | $178.39M | $167.58M | $139.74M | $206.19M | $195.30M | $189.84M | $153.75M | $161.01M | $47.79M | $-917.79K |
| High Forecast | $195.48M | $193.19M | $172.33M | $252.53M | $228.86M | $227.25M | $208.02M | $220.19M | $199.73M | $202.35M | $177.14M | $194.74M | $178.30M | $177.09M | $202.91M | $167.45M | $173.93M | $154.24M | $184.46M | $116.34M | $214.07M | $168.46M | $167.69M | $207.27M | $196.33M | $190.83M | $184.50M | $161.85M | $48.04M | $-900.57K |
| Low Forecast | $187.18M | $184.98M | $165.01M | $241.80M | $219.14M | $217.59M | $199.19M | $210.83M | $191.24M | $193.76M | $169.61M | $186.46M | $170.02M | $169.56M | $135.27M | $159.90M | $167.19M | $147.68M | $122.97M | $111.40M | $142.71M | $164.44M | $111.79M | $202.32M | $191.64M | $186.28M | $123.00M | $157.98M | $46.89M | $-922.60K |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.76% | 0.71% | 0.73% | 0.57% | 0.36% | 0.41% | 0.67% | 0.96% | 0.93% | 0.93% | 1.05% | 1.30% | 0.99% | 2.92% | 44.24% |
Align's average Quarter net income forecast for Mar 24 is $169.09M, with a range of $135.27M to $202.91M. ALGN's average Quarter net income forecast represents a 36.35% increase compared to the company's last Quarter net income of $124.01M (Dec 23).
Align SG&A Forecast
| Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 4 | 5 | 9 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 | 4 | 4 | 4 | 9 | 9 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $401.64M | $407.99M | $453.19M | $439.69M | $410.07M | $398.55M | $426.40M | $439.46M | $451.19M | $428.41M | $431.92M | $397.12M | $348.39M | $312.49M | $256.97M |
| Avg Forecast | $732.18M | $706.84M | $682.38M | $551.77M | $534.96M | $546.22M | $520.23M | $505.23M | $488.73M | $500.02M | $474.54M | $460.06M | $445.83M | $467.38M | $553.30M | $420.52M | $447.90M | $446.49M | $503.00M | $401.66M | $422.31M | $443.48M | $457.27M | $460.89M | $440.40M | $426.68M | $304.72M | $356.28M | $238.37M | $146.47M |
| High Forecast | $736.48M | $710.99M | $686.39M | $555.01M | $538.11M | $549.43M | $523.29M | $508.20M | $491.60M | $502.96M | $477.33M | $462.76M | $446.62M | $470.12M | $663.96M | $423.47M | $453.33M | $449.12M | $603.60M | $404.02M | $506.77M | $445.27M | $548.73M | $462.75M | $442.17M | $428.39M | $365.66M | $357.71M | $239.33M | $147.06M |
| Low Forecast | $712.37M | $687.72M | $663.92M | $536.84M | $520.49M | $531.44M | $506.15M | $491.57M | $475.51M | $486.49M | $461.71M | $447.61M | $444.82M | $454.73M | $442.64M | $418.90M | $440.65M | $434.41M | $402.40M | $390.80M | $337.85M | $437.08M | $365.82M | $454.23M | $434.04M | $420.52M | $243.77M | $351.14M | $234.93M | $144.36M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.96% | 0.91% | 1.02% | 0.87% | 1.02% | 0.94% | 0.96% | 0.96% | 0.98% | 0.97% | 1.01% | 1.30% | 0.98% | 1.31% | 1.75% |
Align's average Quarter SG&A projection for Mar 24 is $553.30M, based on 4 Wall Street analysts, with a range of $442.64M to $663.96M. The forecast indicates a 37.76% rise compared to ALGN last annual SG&A of $401.64M (Dec 23).
Align EPS Forecast
| Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 4 | 5 | 9 | 6 | 4 | 3 | 7 | 4 | 3 | 4 | 7 | 4 | 4 | 4 | 9 | 9 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.64 | $1.59 | $1.46 | $1.14 | $0.54 | $0.93 | $1.44 | $1.71 | $2.42 | $2.29 | $2.53 | $2.54 | $2.02 | $1.77 | $-0.52 |
| Avg Forecast | $2.58 | $2.55 | $2.27 | $3.33 | $3.02 | $3.00 | $2.74 | $2.90 | $2.63 | $2.67 | $2.34 | $2.57 | $2.31 | $2.34 | $1.97 | $2.18 | $2.26 | $2.03 | $1.69 | $1.53 | $2.16 | $2.23 | $2.30 | $2.74 | $2.60 | $2.52 | $2.02 | $2.14 | $0.64 | $-0.01 |
| High Forecast | $2.60 | $2.57 | $2.29 | $3.36 | $3.04 | $3.02 | $2.77 | $2.93 | $2.66 | $2.69 | $2.35 | $2.59 | $2.37 | $2.35 | $1.99 | $2.23 | $2.31 | $2.05 | $1.70 | $1.55 | $2.18 | $2.24 | $2.31 | $2.76 | $2.61 | $2.54 | $2.03 | $2.15 | $0.64 | $-0.01 |
| Low Forecast | $2.49 | $2.46 | $2.19 | $3.21 | $2.91 | $2.89 | $2.65 | $2.80 | $2.54 | $2.58 | $2.25 | $2.48 | $2.26 | $2.25 | $1.90 | $2.13 | $2.22 | $1.96 | $1.63 | $1.48 | $2.08 | $2.19 | $2.25 | $2.69 | $2.55 | $2.48 | $1.98 | $2.10 | $0.62 | $-0.01 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.75% | 0.70% | 0.72% | 0.67% | 0.35% | 0.43% | 0.65% | 0.74% | 0.88% | 0.88% | 1.00% | 1.26% | 0.94% | 2.79% | 42.62% |
According to 4 Wall Street analysts, Align's projected average Quarter EPS for Mar 24 is $1.97, with a low estimate of $1.90 and a high estimate of $1.99. This represents a 20.18% increase compared to ALGN previous annual EPS of $1.64 (Dec 23).
Align Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| ALGN | Align | $243.73 | $554.38 | 127.46% | Buy |
| TNDM | Tandem Diabetes Care | $43.97 | $84.44 | 92.04% | Buy |
| INMD | InMode | $17.04 | $31.40 | 84.27% | Hold |
| NARI | Inari Medical | $46.52 | $72.88 | 56.66% | Buy |
| EW | Edwards Lifesciences | $68.52 | $97.09 | 41.70% | Buy |
| MDT | Medtronic | $90.00 | $106.77 | 18.63% | Hold |
| DXCM | DexCom | $69.51 | $81.86 | 17.77% | Buy |
| PEN | Penumbra | $186.94 | $218.89 | 17.09% | Hold |
| INSP | Inspire Medical Systems | $203.99 | $237.80 | 16.57% | Buy |
| PODD | Insulet | $233.87 | $268.60 | 14.85% | Buy |
| ABT | Abbott Laboratories | $116.40 | $129.50 | 11.25% | Buy |
| TMDX | TransMedics Group | $151.42 | $156.86 | 3.59% | Buy |
| SYK | Stryker | $370.25 | $305.00 | -17.62% | Buy |
| SWAV | ShockWave Medical | $334.75 | $258.17 | -22.88% | Hold |
ALGN Forecast FAQ
Is Align a good buy?
Yes, according to 14 Wall Street analysts, Align (ALGN) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 9 'Buy' recommendations, accounting for 64.29% of ALGN's total ratings.
What is ALGN's price target?
Align (ALGN) average price target is $554.38 with a range of $315 to $790, implying a 127.46% from its last price of $243.73. The data is based on 14 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Align stock go up soon?
According to Wall Street analysts' prediction for ALGN stock, the company can go up by 127.46% (from the last price of $243.73 to the average price target of $554.38), up by 224.13% based on the highest stock price target, and up by 29.24% based on the lowest stock price target.
Can Align stock reach $400?
ALGN's average twelve months analyst stock price target of $554.38 supports the claim that Align can reach $400 in the near future.
What are Align's analysts' financial forecasts?
Align's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $4.37B (high $4.4B, low $4.25B), average EBITDA is $869.17M (high $874.28M, low $845.66M), average net income is $793.34M (high $799.41M, low $765.44M), average SG&A $1.97B (high $1.98B, low $1.92B), and average EPS is $10.55 (high $10.63, low $10.18). ALGN's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $4.78B (high $4.81B, low $4.65B), average EBITDA is $950.7M (high $956.29M, low $924.98M), average net income is $909.71M (high $916.66M, low $877.71M), average SG&A $2.15B (high $2.17B, low $2.09B), and average EPS is $12.09 (high $12.19, low $11.67).
Did the ALGN's actual financial results beat the analysts' financial forecasts?
Based on Align's last annual report (Dec 2023), the company's revenue was $3.86B, beating the average analysts forecast of $3.82B by 1.03%. Apple's EBITDA was $643.34M, missing the average prediction of $807.3M by -20.31%. The company's net income was $445.05M, missing the average estimation of $640.65M by -30.53%. Apple's SG&A was $1.7B, missing the average forecast of $1.82B by -6.49%. Lastly, the company's EPS was $5.81, missing the average prediction of $8.16 by -28.83%. In terms of the last quarterly report (Dec 2023), Align's revenue was $956.73M, beating the average analysts' forecast of $933.67M by 2.47%. The company's EBITDA was $171.54M, missing the average prediction of $185.67M by -7.61%. Align's net income was $124.01M, missing the average estimation of $163.68M by -24.23%. The company's SG&A was $401.64M, missing the average forecast of $420.52M by -4.49%. Lastly, the company's EPS was $1.64, missing the average prediction of $2.18 by -24.63%